| 國立成功大學 |
2022-02-18 |
The Influence of Brand-Generated Content on Customer Engagement and Brand Love on Instagram
|
習娜卡; Laksika, Naksa-ingsart |
| 淡江大學 |
2022-02-18 |
中東歐與台灣: 政治、經濟、貿易、教育與觀光
|
鄭欽模 |
| 國立成功大學 |
2022-02-18 |
Bacterial colonization at caesarean section defects in women of secondary infertility: an observational study
|
Hsu;Isabel;Hsu;Leonard;Dorjee;Sonam;Hsu;Chao-Chin |
| 國立成功大學 |
2022-02-18 |
Beyond Sarcopenia: older adults with type II diabetes mellitus tend to experience an elevated risk of poor dynamic balance-a case-control study
|
Lin;Chih-Chun;Ou;Horng-Yih;Hsu;Hsiu-Yun;Cheng;Kai-Pi;Hsieh;Tai-Jung;Yeh;Chien-Hsien;Su;Fong-Chin;Kuo;Li-Chieh |
| 臺大學術典藏 |
2022-02-18T05:35:26Z |
Aldosterone suppresses cardiac mitochondria
|
Hung, Chi-Sheng; Chang, Yi-Yao; Tsai, Cheng-Hsuan; Liao, Che-Wei; Peng, Shih-Yuan; BO-CHING LEE; Pan, Chien-Ting; Wu, Xue-Ming; ZHENG-WEI CHEN; Wu, Vin-Cent; Wan, Cho-Hua; Young, Morag J; Chou, Chia-Hung; Lin, Yen-Hung |
| 臺大學術典藏 |
2022-02-18T05:41:01Z |
Inadvertent malposition of temporary pacemaker lead in the left ventricle in a patient with acute myocardial infarction
|
ZHENG-WEI CHEN; Pang-Shuo Huang; Po-Chi Lin |
| 臺大學術典藏 |
2022-02-18T05:49:01Z |
Progression of liver fibrosis in a type 2 biliary atresia female baby before hepatoportoenterostomy
|
Chang, CM; Chang, MH; JIA-FENG WU |
| 臺大學術典藏 |
2022-02-18T05:51:13Z |
Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
|
JIA-FENG WU |
| 臺大學術典藏 |
2022-02-18T05:52:36Z |
Immunoglobulin G4-related sclerosing cholangitis in a 3 years of age boy
|
Hsu, CT; Jeng, YM; JIA-FENG WU |
| 臺大學術典藏 |
2022-02-18T05:55:52Z |
Biliary atresia in preterm infants in Taiwan: a nationwide survey
|
Chiu, Chih-Yu; Chen, Po-Hon; Chan, Chan-Fai; Chang, Mei-Hwei; Wu, Tzee-Chung; Taiwan Infant Stool Color Card Study Group (JIA-FENG WU) |
| 臺大學術典藏 |
2022-02-18T06:28:49Z |
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
|
Chiu H.-M.; Jen G.H.-H.; Wang Y.-W.; Fann J.C.-Y.; Hsu C.-Y.; Jeng Y.-C.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; WEN-FENG HSU; Lee Y.-C.; Wu M.-S.; Wu C.-Y.; Jou Y.-Y.; Chen T.H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:49Z |
Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region
|
Chiu H.-M.; Su C.-W.; WEN-FENG HSU; Jen G.H.-H.; Hsu C.-Y.; Chen S.L.-S.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:50Z |
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer
|
Chang L.-C.; Shun C.-T.; Lin B.-R.; Sanduleanu S.; WEN-FENG HSU; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:50Z |
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
|
Peng S.-M.; WEN-FENG HSU; Wang Y.-W.; Lin L.-J.; Yen A.M.-F.; Chen L.-S.; Lee Y.-C.; Wu M.-S.; Chen T.H.-H.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:50Z |
Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy
|
Cheng S.-Y.; Chen C.-F.; He H.-C.; Chang L.-C.; WEN-FENG HSU; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:51Z |
Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program
|
WEN-FENG HSU; Chang C.-Y.; Chang C.-C.; Chang L.-C.; Chen C.-H.; Lin C.-C.; Lin Y.-M.; Lee C.-L.; Wu H.-Y.; Lee H.-C.; Lee Y.-C.; Su M.-Y.; Lin L.-J.; Chia S.-L.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:51Z |
Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing
|
WEN-FENG HSU; Hsu C.-Y.; Yen A.M.-F.; Chen S.L.-S.; Chiu S.Y.-H.; Fann J.C.-Y.; Lee Y.-C.; Chiu H.-M.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:52Z |
Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management
|
WEN-FENG HSU; Cheng S.-Y.; Shun C.-T.; Chang L.-C.; Tu C.-H.; Wang H.-P.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:52Z |
Sampling-based Markov regression model for multistate disease progression: Applications to population-based cancer screening program
|
Hsu C.-Y.; WEN-FENG HSU; Yen A.M.-F.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:52Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:53Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; WEN-FENG HSU; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:53Z |
The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management
|
Onyoh E.F.; WEN-FENG HSU; Chang L.-C.; Lee Y.-C.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:54Z |
Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests
|
Lee Y.-C.; Fann J.C.-Y.; Chiang T.-H.; Chuang S.-L.; Chen S.L.-S.; Chiu H.-M.; Yen A.M.-F.; Chiu S.Y.-H.; Hsu C.-Y.; WEN-FENG HSU; Wu M.-S.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:54Z |
Effects of screening and universal healthcare on long-term colorectal cancer mortality
|
Lee Y.-C.; Hsu C.-Y.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; WEN-FENG HSU; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:55Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; WEN-FENG HSU; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
